ChemiNutra announced that a recent study found its AlphaSize Alpha-Glyceryl Phosphoryl Choline (A-GPC) supported the performance of gamers during virtual reality gameplay.
ChemiNutra (Austin, TX) announced that a recent study found its AlphaSize Alpha-Glyceryl Phosphoryl Choline (A-GPC) supported the performance of gamers. In the randomized, double-blind, placebo-controlled, cross-over study, 13 participants ingested 300 mg of A-GPC in a 4 oz. serving calorie free sports drink or placebo for seven days, with a 14-day wash-out period between supplementation. Following the seven days of supplementation, subjects performed 30 minutes of virtual reality (VR) game play. Prior to game play, mood was measured with Visual Analog Scales for motivation, calmness, focus, fatigue, vigor, and jitteriness. During VR gameplay, researchers looked at the levels completed, attempts per level, and time to complete levels.
Results showed that supplementation with A-GPC increased the number of levels completed by 24.9%, reduced the number of attempts per level by 13.8%, and reduced the time to complete each level by 0.64%. Supplementation also had a positive trend toward vigor and focus compared to placebo, but overall there were no significant changes in mood or videogame behavior following supplementation, indicating that A-GPC does not alter or impair behavior.
The gaming market presents a significant opportunity as 67% of Americans play video games on at least one type of device, according to research from Electronic Entertainment Design and Research.